System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Immacolata Tartaglione is an expert in Hematology at Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli (Italy). As of May 2026, ScienceLeadR ranks Immacolata Tartaglione in the top 1% of experts worldwide for Anemia. Immacolata Tartaglione has authored 66 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 245 (community average: 125). How the SLR is computed.

LeadR Profile

Immacolata Tartaglione Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli Italy
245 ScienceLeadR Reputation 245

Unlock

Register Login
Network Map

Hematology

Subspecialties: Biochemistry - Genetics - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 66

Citations

Citations: 1 161 1st author: 10 Last author: 8 Unique author: 0

Main journals

Blood 11
Am J Hematol 9
Orphanet J Rare Dis 6
Blood Cells Mol Dis 4
Br J Haematol 4

Best Journals

N Engl J Med 2
Nat Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies.
PMID 42050672 — early diagnosis, rare diseases, diagnosis, therapeutics, gaucher disease		Orphanet J Rare Dis20260
Disease Burden in Transfusion-Dependent β-Thalassemia (TDT) Patients and Caregivers in Italy: Results of a Cross-Sectional Descriptive Online Survey.
PMID 41893951 — blood, caregivers, thalassemia, cost of illness		Drugs Real World Outcomes20260
International variations in body mass index within the CASiRe global cohort of sickle cell disease patients.
PMID 41393099 — cells, hemoglobins, body mass index, anemia, sickle cell, obesity, genotype, therapeutics, overweight		J Sick Cell Dis20251
Cerebrovascular involvement in hereditary spherocytosis: observational cohort and case-control MRI study.
PMID 41291755 — rare diseases		Orphanet J Rare Dis20251
Cognitive impairment in hereditary spherocytosis.
PMID 41070673 — hematology, anemia, cognitive dysfunction, cognition disorders		Br J Haematol20250

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 2
Phase 2 1

By status:

Completed 5

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS